According to the United Nations, the proportion of people aged over 65 now outnumber children younger than 5. The enormous growth in the elderly population is posing a socioeconomic challenge to societies worldwide, and necessitates new sweeping interventions for age-associated diseases.
This year we have an incredibly exciting program with global thought-leaders sharing their latest insights into aging and how we target aging process ensuring everyone lives a healthier and longer life.
Welcome to the 13th Aging Research and Drug Discovery Meeting.
SPEAKERS ARDD 2025
Leaders in the aging and longevity field will describe the latest progress in the molecular, cellular and organismal basis of aging and our search for interventions.
Speakers
Michael Levitt
Michael Levitt
Stanford University, USA
Morten Meldal
Morten Meldal
University of Copenhagen, Denmark
Aisyah Sjöholm
Aisyah Sjöholm
Insilico Medicine, USA
Ala Trusina
Ala Trusina
University of Copenhagen, Denmark
Alejandro Aguilera Castrejon
Alejandro Aguilera Castrejon
Howard Hughes Medical Institute Janelia Research Campus, USA
Alessandra Zonari
Alessandra Zonari
OneSkin
Alex Zhavoronkov
Alex Zhavoronkov
Insilico Medicine, USA
Alexey Terskikh
Alexey Terskikh
Harry Perkins Institute & University of Western Australia, Australia
Amy Morgan
Amy Morgan
The University of Salford, UK
Ana Maria Cuervo
Ana Maria Cuervo
Albert Einstein College of Medicine, US
Anastasia Georgievskaya
Anastasia Georgievskaya
Haut.AI, Estonia
Andrea Maier
Andrea Maier
National University of Singapore, Singapore
Andrea Heinz
Andrea Heinz
University of Copenhagen
Andreas Beyer
Andreas Beyer
Institute for Genetics, Faculty of Medicine, University of Cologne, Germany
Andrei Seluanov
Andrei Seluanov
University of Rochester, US
Andrew Adams
Andrew Adams
Eli Lilly and Company, USA
Andy Poyi Tsai
Andy Poyi Tsai
Stanford University, USA
Anna Murray
Anna Murray
University of Exeter, England
Anne Brunet
Anne Brunet
Stanford University, USA
Anne Marije van Harten
Anne Marije van Harten
Apollo Health Ventures, Luxembourg
Anthony Atala
Anthony Atala
Wake Forest Institute for Regenerative Medicine, USA
Avi Spier
Avi Spier
Novartis, Switzerland
Axel Kowald
Axel Kowald
Institute for Biostatistics & Informatics in Medicine and Ageing Research
Bartlomiej Piechowski-Jozwiak
Bartlomiej Piechowski-Jozwiak
Institute for Healthier Living Abu Dhabi, United Arab Emirates
Ben Shenhar
Ben Shenhar
Weizmann Institute of Science
Benjamin Johnson
Benjamin Johnson
Nature Health, UK
Benjamin Friedrich
Benjamin Friedrich
Technische Universität Dresden, Germany
Bente Klarlund
Bente Klarlund
University of Copenhagen, Denmark
Berthil Clasen
Berthil Clasen
Eli Lilly and Company, USA
Björn Schumacher
Björn Schumacher
University of Cologne, Germany
Brian Kennedy
Brian Kennedy
National University of Singapore, Singapore
Charlotte Suetta
Charlotte Suetta
University of Copenhagen, Denmark
Christiane Volbracht
Christiane Volbracht
Lundbeck
Christoph Kuppe
Christoph Kuppe
Aachen University, Germany
Chuen Yan Leung
Chuen Yan Leung
Value Partners Group, Hong Kong
Clive Cookson
Clive Cookson
Financial Times, UK
Collin Ewald
Collin Ewald
Novartis Biomedical Research Diseases of Aging and Regenerative Medicine, Switzerland
Cristiana Banila
Cristiana Banila
Mitra Bio, UK
Daniela Bakula
Daniela Bakula
University of Copenhagen, Denmark
Dario Valenzano
Dario Valenzano
Leibniz Institute on Aging, Germany
David Dodick
David Dodick
Mayo Clinic, USA
David Dreyer Lassen
David Dreyer Lassen
University of Copenhagen, Denmark
David Helmut Meyer
David Helmut Meyer
University of Cologne
Denis Villemonais
Denis Villemonais
University of Strasbourg, France
Denis Sarigiannis
Denis Sarigiannis
National Hellenic Research Foundation
Dominik Duscher
Dominik Duscher
MuseCell Innovations, Singapore
Dudley Lamming
Dudley Lamming
University of Wisconsin-Madison, USA
Edward Rudnic
Edward Rudnic
Maxwell Biosciences, USA
Elena Sergeeva
Elena Sergeeva
Tufts University, USA
Elena Bonfiglioli
Elena Bonfiglioli
Pharma and Life Sciences Microsoft
Elias Bou Samra
Elias Bou Samra
L'Oréal Research & Innovation, France
Elise Cachat
Elise Cachat
University of Edinburgh, Scotland
Emma Teeling
Emma Teeling
University College Dublin, Ireland
Eric Verdin
Eric Verdin
Buck Institute for Research on Aging, USA
Ethan Liu
Ethan Liu
Westlake University, China
Evandro Fang
Evandro Fang
University of Oslo, Norway
Evelyne Bischof
Evelyne Bischof
Sheba Longevity Center, Tel Hashomer
Fabrizio d'Adda di Fagagna
Fabrizio d'Adda di Fagagna
IFOM; IGM-CNR, Italy
Fedor Galkin
Fedor Galkin
Insilico Medicine, UAE
Garegin Papoian
Garegin Papoian
Deep Origin, USA
Gareth Shepherd
Gareth Shepherd
NHS and AFAR
Garri Zmudze
Garri Zmudze
LongeVC, Switzerland
Geoffrey West
Geoffrey West
Santa Fe Institute, USA
Glen Pridham
Glen Pridham
Weizmann Institute of Science
Heike A. Bischoff-Ferrari
Heike A. Bischoff-Ferrari
University of Basel, Switzerland
Henri Jasper
Henri Jasper
Genentech / Roche, USA
Hilde Loge Nilsen
Hilde Loge Nilsen
AgeLab.no, Norway
In Hwa Jang
In Hwa Jang
University of Minnesota, USA
Jackie Han
Jackie Han
Peking University, China
Jacob Falck Hansen
Jacob Falck Hansen
Lundbeckfonden BioCapital, Denmark
James Kirkland
James Kirkland
Robert and Arlene Kogod Center on Aging, USA
Jamie Justice
Jamie Justice
XPRIZE Healthspan, USA
Jan Hoeijmakers
Jan Hoeijmakers
University of Cologne, Germany
Jan Gruber
Jan Gruber
National University of Singapore, Singapore
Jaron Rabinovici
Jaron Rabinovici
Sheba Medical Center
Javier Maria Peralta Ramos
Javier Maria Peralta Ramos
Weizmann Institute of Science, Israel
Jean-Marc Lemaitre
Jean-Marc Lemaitre
Institute of Regenerative Medicine and Biotherapies of Montpellier, France
Jeffrey West
Jeffrey West
H. Lee Moffitt Cancer Center & Research Institute, US
Jeroen Aerssens
Jeroen Aerssens
Rejuvenate Biomed, Belgium
Jerome Feige
Jerome Feige
Nestlé, Switzerland
Joe Betts-LaCroix
Joe Betts-LaCroix
Retro Biosciences, USA
John Newman
John Newman
Buck Institute, US
Jonathan Gootenberg
Jonathan Gootenberg
Harvard Medical School, USA
Juan Carlos Izpisua Belmonte
Juan Carlos Izpisua Belmonte
Altos Labs, USA
Jun Wu
Jun Wu
University of Texas Southwestern Medical Center, USA
Kazuto Kawamura
Kazuto Kawamura
Max Planck Institute for Biology of Ageing
Kennedy  Schaal
Kennedy Schaal
Rejuve.Bio, US
Kitsu Egerton
Kitsu Egerton
Baillie Gifford, UK
Kristen Fortney
Kristen Fortney
BioAge Labs, USA
Kotb Abdelmohsen
Kotb Abdelmohsen
National Institutes of Health, USA
Kunlin Jin
Kunlin Jin
Aging and Disease
Kyle Loh
Kyle Loh
Stanford University, USA
Laura Niedernhofer
Laura Niedernhofer
University of Minnesota Medical School, USA
Leo Lopez
Leo Lopez
Tufts University, USA
Lida Katsimpardi
Lida Katsimpardi
Institute for Regenerative Medicine and Biotherapies, IRMB, France
Lisa Melton
Lisa Melton
Nature Biotechnology, UK
Lotte Bjerre Knudsen
Lotte Bjerre Knudsen
Novo Nordisk, Denmark
Luc Aguilar
Luc Aguilar
L'Oréal Research & Innovation, France
Lucas Camillo
Lucas Camillo
Shift Bioscience
Lucia Marucci
Lucia Marucci
University of Bristol
Luigi Ferrucci
Luigi Ferrucci
National Institute on Aging, USA
Lykke Sylow
Lykke Sylow
University of Copenhagen, Denmark
Mahdi Moqri
Mahdi Moqri
Harvard University, USA
Marc Bernegger
Marc Bernegger
Maximon, Switzerland
Marco Demaria
Marco Demaria
European Research Institute for the Biology of Ageing (ERIBA)
Marija Cvijovic
Marija Cvijovic
University of Gothenburg and Chalmers University of Technology, Sweden
Marissa Schafer
Marissa Schafer
Mayo Clinic, USA
Marta Guasch-Ferré
Marta Guasch-Ferré
University of Copenhagen, Denmark
Martin Borch Jensen
Martin Borch Jensen
Gordian Biotechnology
Maximina Yun
Maximina Yun
Sheikh Zayed Genetic Research Centre,Wew, UAE
Max Unfried
Max Unfried
National University of Singapore, Singapore
Max Wilson
Max Wilson
University of California, Santa Barbara, USA
Michael Ringel
Michael Ringel
Life Biosciences, USA
Michael Antonov
Michael Antonov
Deep Origin, USA
Michela Deleidi
Michela Deleidi
Institut Imagine, France
Miriam Merad
Miriam Merad
Mount Sinai School of Medicine in New York, USA
Mirre Simons
Mirre Simons
University of Sheffield
Morten Scheibye-Knudsen
Morten Scheibye-Knudsen
University of Copenhagen, Denmark
Mourad Topors
Mourad Topors
Repair Biotechnologies, USA
Murali Venkatesan
Murali Venkatesan
Danaher Corporation, USA
Nan Hao
Nan Hao
University of California San Diego,
Nathan LeBrasseur
Nathan LeBrasseur
Mayo Clinic, USA
Naveh Raz
Naveh Raz
Weizmann Institute of Science
Neda Bagheri
Neda Bagheri
University of Washington, USA
Niklas Anzinger
Niklas Anzinger
Infinita City, Honduras
Nir Barzilai
Nir Barzilai
Albert Einstein College of Medicine, USA
Omar Abudayyeh
Omar Abudayyeh
Harvard Medical School, USA
Paul Kohlhaas
Paul Kohlhaas
Molecule, Switzerland
Peter Mullen
Peter Mullen
University of Southern California, USA
Peter Fedichev
Peter Fedichev
Gero, Singapore
Peter Lidsky
Peter Lidsky
City University of Hong Kong, Hong Kong
Philipp Gut
Philipp Gut
Nestlé, Switzerland
Priya Singhal
Priya Singhal
Biogen, USA
Rafael de Cabo
Rafael de Cabo
National Institute on Aging, USA
Riekelt Houtkooper
Riekelt Houtkooper
University of Amsterdam, Netherlands
Risa Starr
Risa Starr
Academy for Health and Lifespan Research
Rusty Montgomery
Rusty Montgomery
BioAge Labs, USA
Ryan Smith
Ryan Smith
TruDiagnostic, USA
Sam Burrows
Sam Burrows
NHS Frimley ICB, UK
Sara Hägg
Sara Hägg
Karolinska Institutet
Sara Bonnes
Sara Bonnes
Mayo Clinic
Sebastian Lobentanzer
Sebastian Lobentanzer
Helmholtz Center
Sebastien Thuault
Sebastien Thuault
Nature Aging, US
Sergey Jakimov
Sergey Jakimov
LongeVC, Switzerland
Shahaf Peleg
Shahaf Peleg
FBN Dummerstorf, Germany
Sharon Rosenzweig-Lipson
Sharon Rosenzweig-Lipson
Life Biosciences, USA
Sophia Liu
Sophia Liu
Ragon Institute of MGB, MIT, and Harvard, USA
Steffen Rulands
Steffen Rulands
Ludwig-Maximilians-Universität München, Germany
Steve Horvath
Steve Horvath
Altos Labs, USA
Steve Austad
Steve Austad
University of Alabama Birmingham, USA
Thomas Rando
Thomas Rando
University of California Los Angeles, USA
Tina Woods
Tina Woods
Exposome Moonshot
Tom Zuber
Tom Zuber
Zuber Lawler, USA
Tomás Schmauck-Medina
Tomás Schmauck-Medina
University of Oslo
Tomaz Rozmaric
Tomaz Rozmaric
Ludwig Boltzmann Institute for Traumatology in Vienna
Tony Wyss-Coray
Tony Wyss-Coray
Stanford University, USA
Tuomas Tammela
Tuomas Tammela
Memorial Sloan Kettering Cancer Center, US
Tzipora Strauss
Tzipora Strauss
Longevity Center at Sheba Medical Center
Uri Alon
Uri Alon
Weizmann Institute of Science
Vadim Gladyshev
Vadim Gladyshev
Harvard Medical School, USA
Vera Gorbunova
Vera Gorbunova
University of Rochester, US
Vijay Vaswani
Vijay Vaswani
Omniscope, USA
Wanviput Sanphasitvong
Wanviput Sanphasitvong
Virallife Scientific Wellness Center/ Bumrungrad International
Wei-Wu He
Wei-Wu He
Human Longevity Inc.
Weilan Wang
Weilan Wang
National University of Singapore,Singapore
Wenting Zhao
Wenting Zhao
Nanyang Technological University, Singapore
William Harborne
William Harborne
LongGame, United Kingdom
XingLi Wang
XingLi Wang
Fosun Pharma, China
Yousin Suh
Yousin Suh
Columbia University, USA
Yujiiang Shi
Yujiiang Shi
Fudan University, China
Yusuf Roohani
Yusuf Roohani
Arc Institute, USA
Yuta Lee
Yuta Lee
Accelerated Biosciences, USA
Zane Koch
Zane Koch
University of California San Diego
Todd White
Todd White
The Thalion Initiative, USA
Andrea Olsen
Andrea Olsen
California Institute of Technology, USA
Sierra Lore
Sierra Lore
Buck Institute for Research on Aging, USA
Dominika Wilczok
Dominika Wilczok
Duke University
Charlotte Owen-Woods
Charlotte Owen-Woods
Cell
Lars Hartenstein
Lars Hartenstein
McKinsey Health Institute
Andrea Cipriano
Andrea Cipriano
Stanford
Aleksandr Tyshkovskiy
Aleksandr Tyshkovskii
Harvard Medical School
Daisy Cai
Daisy Cai
B Capital
Vanessa Sinatti
Vanessa Sinatti
Aptah Bio
Bohan Zhang
Bohan Zhang
Harvard Medical School
More speakers to be announced

ARDD Sponsors 2025

Sponsorship Enquiry:
Morten Scheibye-Knudsen | mscheibye@sund.ku.dk
Tier 1 Sponsors
Tier 2 Sponsors
Tier 3 Sponsors
Tier 4 Sponsors
Tier 5 Sponsors

Knowledge & Education Partners

ARDD Knowledge Partner
ARDD Education Partner
ARDD Education Partner
ARDD Education Partner

Media Partners

Nature Health
Watch the presentations from the largest aging research
and drug discovery meeting free at your own pace
CHAIRS
"We are really looking forward to this year's ARDD meeting. We are extremely humbled, honored and excited that so many amazing speakers will join our meeting that will be onsite at the University of Copenhagen. This year we maintain our focus on young scientists who will be the future of our field and we have a large amount of speaker slots for these rising stars. In addition, the highly succesful Longevity Medicine workshop will be repeated and we are in the process of organizing further exciting workshops. More to come!"
Morten Scheibye-Knudsen
The University of Copenhagen
  • Morten Scheibye-Knudsen
    The University of Copenhagen
  • Daniela Bakula
    The University of Copenhagen
  • Alex Zhavoronkov
    Insilico Medicine
People
  • Morten
    Scheibye-Knudsen
    with the ARDD team since 2016
  • Daniela Janina
    Bakula
    with the ARDD team since 2019
  • Alex
    Zhavoronkov
    with the ARDD team since 2014
  • Evelyne Yehudit
    Bischof
    with the ARDD team since 2021
  • Max
    Unfried
    with the ARDD team since 2022
  • Stephanie
    Tsang
    with the ARDD team since 2022
Recommended Reading
Subscribe to our news!
ARDD Quotes
  • Really enjoyed the breadth of talks and discussions.
    Michael Levitt
    Nobel Prize in Chemistry 2013
    Stanford
  • Phenomenal conference in the Rejuvenation Field.
    Steve Horvath
    Principal Investigator
    Altos Lab
  • Where one can learn about aging scientifically, clinically and in real life.
    Xingli Wang
    Fosun Global Partner
    Fosun Pharma
  • The ARDD event pioneers the future of healthy aging, driving breakthroughs in longevity research while opening a new era of cosmetic innovation
    Luc Aguilar
    Chief Scientific Officer
    L’ORÉAL R&I
  • The Aging Research and Drug Discovery Meeting was a great opportunity to see where the world is in terms of cutting edge research focused on the biology of aging and mechanisms that could help treat or prevent age-related disorders. It’s perhaps the preeminent meeting of this kind.
    David Glass
    Vice President, Research
    Regeneron
  • The ARDD 2024 conference was the ultimate go to meeting for ageing research, covering a broad range of topics from genetics, genomics, proteomics, basic molecular and biological mechanism to interesting validation of concepts in cellular systems and animal systems. The question underpinning the conference is gigantic and existential for mankind; how to prolong lifespan with maintained quality of life.
    As the head of R&D for Lundbeck, a pharmaceutical company focusing on diseases of the nervous systems, I find it challenging, still very intriguing and highly interesting to engage in the scientific community on the very topic of aging with maintained brain health. I am therefore very much looking forward to the 2025 ARDD conference, as another opportunity to build scientific networks and learn about the most recent research on longevity.
    Johan Luthman
    Executive Vice President, R&D
    Lundbeck
  • The ARDD conference has become the premier meeting in Europe to learn the latest advances in the biology of aging and development of medicines to delay it
    David Sinclair
    Harvard Medical School

This was a great event which brought together academics and industry to find out about the latest developments the field of ageing.

Amy Morgan

University of Salford

It was an excellent meeting!

Peter Lidsky

City University of Hong Kong

The finest aging meeting there is for bringing diverse stakeholders together.

Steve Austad

University of Alabama at Birmingham

best aging meeting of the circuit

fabrizio d'adda di fagagna

IFOM & CNR

Just great

Max

Gero

Everything was perfectly arranged.

Xiaodong Liu

Westlake university

Without doubt this conference is the BEST in ageing and longevity research!

Christoph Kuppe

RWTH Aachen University

Probably the best week of the year for me...

Pierre Jacob

Heidelberg University

ARDD was a unique mix of industry and academia where the cutting edge aging researchers were able to exchange ideas with biotech and pharma luminaries working on translation of these discoveries.

Max Wilson

University of California Santa Barbara

By combining practitioners with basic research, particularly with physics in aging this was both a unique and a very stimulating meeting which I very much enjoyed.

Geoffrey West

Santa Fe Institute

Ageing insights

Trevor Archer

Longevience

It has been my first ARDD - but for sure not my last. - Great organisation!!!!

Michael Schaeffler

Cfm Oskar Tropitzsch GmbH

The biggest event not just in aging research, but perhaps, in biomedical science in general

Fedor Galkin

Insilico Medicine

Fantastic conference - the meeting is a window showcasing the state-of-the art of aging research. It is THE annual event that brings the people in the field together, but also brings new people into the field.

Shahaf Peleg

FBN Dummerstorf

What I loved about ARDD 2025? Brilliant science, thought-provoking panels, and the kind of networking that turns colleagues into collaborators (and occasionally into late-night debate partners). A truly inspiring meeting -- thanks to the organizers!

Marco Demaria

European REsearch Institute for the Biology of Ageing (ERIBA)

Very good service and a many interesting lectures

Tomas Lenz

Longevience AB

ARDD had great speakers, great atmosphere and awesome vibes. I learned a lot, connected and just had fun.

Naveh Raz

Weizmann Institute of Science

Dynamic interactions among academics, clinicians, and industry professionals. Lots of stimulating discussion. Really enjoyable!

Wenting ZHAO

Nanyang Technological University

I truly appreciate being a part of ARDD 2025 and meeting world leaders in the field of healthy longevity

Bartlomiej Piechowski-Jozwiak

Institute for Healthier Living Abu Dhabi

Unique opportunity for industry and academic research to come together

Anonymous

ARDD has become the premier event in longevity pharmacology, drawing hundreds of participants with tremendous enthusiasm and energy.

Joao Pedro Magalhaes

University of Birmingham

To advance anti-aging and rejuvenation technology, we need to focus on reality, as Nature and time can't be fooled.

Lingyan Shi

University of California, San Diego

The science is phenomenal and represents state-of-the-art research in healthspan extending research globally from academic and industry leaders. There is a magical, collaborative atmosphere.

Laura Niedernhofer

UMN

ARDD 2025 delivered a unique rigorous and forward-looking program. It is an excellent meeting to challenge ideas and initiate new collaborations

LEMAITRE

INSERM

Outstanding event which delivers a huge volume of educational content on the state of the art in aging and drug discovery research. ARDD offers great opportunities to network with established leaders and rising stars in the field over meals and beverages, which were all generously provided for. Returning for the second year, seeing familiar faces, and making lasting connections was a pleasure and I am very glad to have participated once again. I highly recommend this event for medical researchers, entrepreneurs, or enthusiasts alike.

Thomas Guttenberger

Metacoder AI

The ARDD conference was exceptionally well organized, with a thoughtfully curated program that brought together cutting-edge topics at the intersection of aging research, drug discovery, and AI. It was inspiring to see how the event set an example for how industry and academia can engage productively, bridging perspectives to drive innovation forward. ARDD truly demonstrated how conferences can not only share knowledge but also shape the future of the field.

Marija Cvijovic

Mathematical Sciences, University of Gothenburg

ARDD is an invaluable meeting that bridges basic science with clinical translation, making it a leading forum for advancing aging research and drug discovery. It’s an incredible opportunity to engage with a global community of scientists and industry leaders who share the goal of extending healthspan by targeting the biology of aging. I was proud to present Life Biosciences’ progress in cellular rejuvenation, and as an ARDD sponsor, we were able to highlight our pioneering work while fostering relationships that will help move the entire field forward.

Sharon Rosenzweig-Lipson

Life Biosciences

I am VERY impressed with the quality of people and diverse range of ARDD attendees: academics, companies, medical doctors, investors, longevity enthusiasts, research scientists, thought leaders. Everyone attending was fully invested in absorbing the event content, having fun and forming lasting connections. This was by far the most engaged conference audience I've come across. Being surrounded by the energy of so many brilliant minds all invested in creating lasting change in the world for five days and nights provides a unique bonding experience. I am excited to see what the future holds as this amazing community works together to create long-term health & wellness globally!

Sarah Aubrey

Maxwell Biosciences

The conference featured an outstanding lineup of speakers, each offering novel insights and innovative perspectives into the field of aging research. The audience was highly engaged, representing a diverse range of research fields, which provided an excellent networking opportunity. Taken together, ARDD offers a unique chance to connect, share ideas, and stay at the forefront of current aging research. I look forward to the next ARDD.

Andrea Heinz

Department of Pharmacy, University of Copenhagen

ARDD 2024 was one of the most exciting meetings I have ever been to. It brought together great scientists from academia, biotech, and pharma, it promoted positive interactions for funding opportunities and startups,and created a great forum for brainstorming and hearing about transformative technologies in the workshops. And Alex’s proposal to Dominika most memorable!

Adam Antebi

Max Planck Institute for BIology of Ageing, Cologne, Germany

We are at a pivotal moment. The stars have aligned to make real progress in understanding aging and ultimately extending longevity. I found ARDD to be the nexus where diverse perspectives converge, accelerating this progress.

Albert-László Barabási

Northeastern University

Attending for the first time, I found the ARDD conference to be a remarkable forum for exchanging groundbreaking ideas and accelerating the science of healthy longevity. The collective commitment to pushing the boundaries of research and making a lasting impact is truly inspiring

Alireza Haghighi

Harvard Medical School

The ARDD is THE state-of-the-art event for entrepreneurs, scientists, clinicians and investors to shape the future of health optimization. It is not only scientifically stimulating, but also the most important meeting to build social interconnections within our field.

Andrea Maier

National University of Singapore

ARDD2024 has been a very inspiring, high-quality scientific event

Andreas Beyer

University of Cologne

ARDD was a wonderful conference that highlighted many recent advances in aging research. It was also great to see aging research translating into potentially life-saving and life-extending treatments for many age-related illnesses

Anthony Schwartz

VitaDao

ARDD has a very particular vibe. It manages to be a hardcore longevity conference and at the same time, a lot of fun. Here, it’s easy to catch up with the latest research and breakthroughs in the field, have some quality time with old friends, and make new ones. For me as a journalist, ARDD is also a major source of stories that packs my interview schedule for months ahead.

Arkadi Mazin

Staff writer at Lifespan.io

The ARDD2024 once again showcased the thrives that the field of the biology of aging has been making from discovery science to medical translation. For the first time we can now target the mechanisms of aging such as genome instability, which drives aging at the very root cause, while at the same time we can now quantify biological age thus enabling clinical testing of geroprotective interventions

Björn Schumacher

University of Cologne

Once again, ARDD has proven to be the best longevity conference of the year - diverse attendees with varied expertise, exciting talks and a perfect atmosphere. I am already looking forward to next year to see what they think of next.

Brian Kennedy

National University of Singapore

As a first time attendee, the diversity of excellent research, and the ability to interact with companies or investors or the scientists performing work at the bench, that could be found at ARDD, provided a unique opportunity for me. I have never encountered this breadth of individuals at a conference. It was a wealth of new data, and included good conversation about my own research. I am already in conversation about experiments with international colleagues that I couldn't have met without attending ARDD.

Christina Camell

University of Minnesota

ARDD is the "must go" conference for aging science and longevity. It brings together world-renowned experts in the field of aging, as well as longevity investors and practitioners. The venue is outstanding, and the activities planned by the organizers are super fun!

David Furman

Buck Institute

As an inventor, it was wonderful to learn about many open challenges in the fields of aging and longevity, for which we could build new tools. Great technologies should be driven by great questions and problems, and aging and longevity tie to many of the core questions and problems at the heart of diseases, human suffering, and human well-being.

Ed Boyden

MIT

ARDD continues to impress me with its interdisciplinary approach, bringing together cutting-edge research from across fields. This year was particularly remarkable, with scientists from diverse disciplines, such as bioengineering (organs-on-chips/ organoid fields), AI life models, and genetic medicine, all contributing invaluable insights. The synergy at the intersection of these fields was inspiring and essential for advancing our understanding of ageing and future longevity developments. I am honoured to be part of such a transformative event.

Emad Moeendarbary

University College London

ARDD2024 is probably one the best organized events I have ever attended. It was great to meet so many top anti-aging researchers in person, some of whom originally inspired me to start working in this field

Fedor Galkin

Insilico Medicine

Presenting at the conference this year was a profound reminder of the power of collaboration and innovation. The exchange of ideas between Academy and Industry ignited a collective enthusiasm in the ageing field that will undoubtedly drive our future endeavors. It's inspiring to see how we can transform challenges into opportunities when the two worlds collide.

Filipe Cabreiro

University of Cologne

By a wide margin, the ARDD is the perfect place to meet both scientists and entrepreneurs who want to foster longevity science. So if you want long and healthy lives, ARDD is the conference to attend.

Georg Fuellen

Universität Rostock

ARDD is the premier conference for anyone seeking the latest updates in aging research, science, and technology. I’ve attended for the past three years and plan to return next year. The event has helped me build valuable connections and friendships, as well as generate numerous leads. I highly recommend it to anyone in the field!

Gil Blander

InsideTrackers

I greatly enjoyed ARDD2024! This was certainly the best Geroscience meeting I ever attended. I liked especially the combination of basic science and applied research, the latter often by start-up companies. One major effect of ARDD is that many basic scientists now begin to take an active interest in translating and commercializing their own research. It is this what makes Geroscience blossom into a future of improved health span

Jan Vijg

Albert Einstein College of Medicine

ARDD is one of the most important and exciting conferences in the aging field. The combination of speakers and attendees from across academic, pharma, biotech, and other sectors that the organizers achieved is truly unique, and the programs have been consistently excellent since I began attending. Notable features of the 2024 conference were the expanded representation by pharma and the dedicated sessions on XPRIZE healthspan, physics in aging, and longevity medicine. I am already looking forward with excitement to see what ARDD has in store for 2025.

Jesse Potanik

Harvard Medical School

This is a great event to find out about some of the early breakthroughs in aging research without the marketing spin and hype. I appreciated the mix of researchers from different countries as well as the reality check from pharma companies on how hard it is to bring aging drug discoveries to people. I would recommend having a media event that helps summarize some of the key discoveries or themes for a wider audience.

Jessica Davis Plüss

Journalist at SWI swissinfo.ch

The ARDD conference is a unique high-level scientific meeting in aging research that facilitates discussions with the world’s leading experts in the field. Both at the preclinical level and for clinical trials, academics and start-ups present their work and outline new directions for the sector. In its latest edition in 2024, the organizers included workshops where researchers and company representatives discussed their methods and results in detail in a friendly atmosphere, similar to a lab meeting with team members. Everything takes place in beautiful Copenhagen, which is a plus!

Mar de Miguel

Staff writer at BioWorld

The 11th ARDD meeting brought together the best of academia, industry, and innovative discourse under one roof, with the goal of advancing healthy aging for all. I am grateful for the organisers’ commitment to creating an inclusive platform, where researchers and entrepreneurs of all career stages can present diverse views on leading developments in the aging field

Matthew Key

University of Southern Denmark

ARDD is a wonderful conference because it brings together researchers, clinicians, industry leaders, investors, and even big pharma to discuss longevity and aging against the beautiful backdrop of Copenhagen! We loved absorbing cutting edge science, catching up with colleagues, and establishing novel collaborations with new friends!

Max Shokhirev

Tally Health

ARDD is a premiere event in what is going to be the most important space for biomedical research in the future—how to extend healthspan and lifespan for everyone. It brings together a spectacular set of basic researchers, biotech entrepreneurs, investors, and large pharmaceutical company representatives to develop solutions and build connections for how we advance this cause

Michael Ringel

BCG

The ARDD2024 was a fantastic event bringing the worlds leading researchers in the aging field together to a konference on the highest international level. As an invited speaker in the session 'Physics in Aging Biology' I experienced presentations with very high quality which put the scale for physical modelling on the highest level. The konference as a whole was excellently organized on the beautiful premises of Copenhagen University

Mogens Høgh Jensen

University of Copenhagen

The ARDD2024 conference was a fantastic opportunity to witness groundbreaking aging research and the translation of ideas into action, with participation from leading pharma, biotech, and academic experts. The event was brilliantly organized, not just for absorbing insights from top minds in the field but also for meaningful conversations and networking. I went home refreshed and buzzing with excitement about the future of aging research.

Naisha Shah

BioAge

If I could describe my experience in one word, it would be connection. Witnessing the commencement of a shift towards a new clinical specialty called "healthy longevity medicine", we can see how applying systems thinking in biology and in technology can bring the latest evidence can be linked to actionable insights today. From the interrelation between AI technology and medicine to in-depth discussions on geroscience and senolytics, it is these connections that will allow us to achieve the future of healthy longevity medicine.

Nicole Sirotin

Institute for Healthier Living Abu Dhabi

The energy in this meeting was incredible. It was especially nice to see the engagement from interdisciplinary scientists, as success in this field will clearly require experimental, technological, and conceptual breakthroughs

Omer Karin

Imperial College London

In the field of Aging and Longevity, most conferences tend to be either overly theoretical or heavily focused on business. ARDD stands out as one of the few meetings that strikes the ideal balance between academic translation and industrial scientific rigor. And this is why as a scientist and as an investor I thoroughly enjoy ARDD because it brings together the most diverse and distinguished group of leaders to discuss, deliberate and drive the field of aging and longevity forward

Reghav Seghal

Healthy Longevity Clinic

ARDD continues to be one of the most enriching and scientifically exhilarating conferences in the healthspan community. It attracts some of the best academic and start-up talent in the world and is a beacon to understanding the advancements taking place in the longevity community

Robin Mansukhani

Deciduous Therapeutics

The ARDD conference keeps developing for each year and the ARDD2024 version was a great experience with the addition of different parallel sessions. I also enjoyed meeting so many friends and colleagues from around the world and the networking opportunities are endless. From now on, it is one of the essential yearly conferences for me!

Sara Hääg

Karolinska Institute

Not only does ARDD feature some cutting-edge research but it's also a great opportunity to meet and connect with various stakeholders, including newcomers, and sample views and opinions from different corners of the field. ARDD has a really positive vibe and I always end that last week of August in the beautiful city of Copenhagen feeling energized in spite of the long sessions and the intensity of the meeting! ARDD is one of those events in the aging and longevity space that you don't want to miss.

Sebastien Thuault

Chief Editor of Nature Aging

I will never forget the ARDD conference in Copenhagen in August 2024. The phenomenal talks by leading scientists on promising rejuvenating interventions made me very hopeful for the future.

Steve Horvath

Altos Lab

I attended ARDD2024 for the first time because I was invited to give a talk. As a synthetic biologist who entered the field of aging research in 2024, I learned tremendously from the presentations and discussions. Life is short, and longevity research is long, so why don't we start it now by learning from and attending ARDD2025?

Tae Seok Moon

Professor at J. Craig Venter Institute

ARDD has just become a go-to meeting in the aging and longevity space. No other meeting brings together such a diverse array of experts, ranging from academic research, the investment community, and the start-up/biotechnology world.

Thomas Rando

Stanford University

It will be a pleasure for me to say that ARDD is by far the most educative academic and serious conference in the world of longevity and I hope more to come.

Tzipi Strauss

Sheba Medical Center

The Physics of Aging session was the first of its kind – truly revolutionary

Uri Alon

Weizmann Institute of Science

ARDD is my favorite conference! The quality of the science was top notch, topics were exciting, and the atmosphere was inspiring and energizing.

Vera Gorbunova

University of Rochester

ARDD is one of the most remarkable conferences in the field. It brings together several reputable KOLs giving a deep and broad perspective of where the science is and soon will be and the clinical implementations of such discoveries. ARDD is a think tank and a must for those who want to make a tangible difference in healthy aging research

Vittorio Sebastino

Turn.bio

What I love about ARDD is the breadth of strategies, depth of scientific knowledge, and the consistency of supportive and collaborative people that attend this meeting. No matter what strategies you believe in, for this one week in Copenhagen, we are united in spirit to strive for healthspan and lifespan. It is a truly inspiring event.

Yuta Lee

Accelerated Biosciences

ARDD was an exceptional event, uniting leaders from science, business, investment, and healthcare to accelerate progress toward living better, longer.

Zoe Du

Buck Institute

It was my first ARDD event and I've immediately become a fan of this yearly series! It was very unlike a typical conference, Instead, it was like a scientific and business club of the highest caliber. People shared cutting edge research, ideas, networked and conducted business, but also had a lot of fun in such a natural way and so relevantly, it felt like the whole event was designed to be a thematic party.
But the true value was the level of insight. The organizers managed to strike a rare balance between strategic or even educational presentations, and deeply technical ones, sharing cutting edge advances in science and tech. You can judge the quality of the event when you attend the last lecture of the day at 20.30 and the hall is literally packed...Not a typical thing at a conference"

Andrii Buvailo

Co-founder & publisher BioPharmaTrend.com